Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence - PubMed (original) (raw)

. 2021 Feb 6;397(10273):452-455.

doi: 10.1016/S0140-6736(21)00183-5. Epub 2021 Jan 27.

Lewis F Buss 2, Maria P S Carvalho 3, Carlos A Prete Jr 4, Myuki A E Crispim 3, Nelson A Fraiji 3, Rafael H M Pereira 5, Kris V Parag 6, Pedro da Silva Peixoto 7, Moritz U G Kraemer 8, Marcio K Oikawa 9, Tassila Salomon 10, Zulma M Cucunuba 6, Márcia C Castro 11, Andreza Aruska de Souza Santos 12, Vítor H Nascimento 4, Henrique S Pereira 13, Neil M Ferguson 6, Oliver G Pybus 8, Adam Kucharski 14, Michael P Busch 15, Christopher Dye 8, Nuno R Faria 16

Affiliations

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence

Ester C Sabino et al. Lancet. 2021.

No abstract available

PubMed Disclaimer

Figures

Figure

Figure

COVID-19 hospitalisations, excess deaths, and Rt in Manaus, Brazil, 2020–21 (A) Dark lines are the 7-day rolling averages and lighter lines are the daily time series of COVID-19 hospitalisations and excess deaths. Hospitalisation data are from the Fundação de Vigilância em Saúde do Amazonas. Total all-cause deaths for 2020–21 were reported initially by the Prefeitura de Manaus and subsequently in the daily COVID-19 bulletin of the Fundação de Vigilância em Saúde do Amazonas. All-cause deaths from 2019 were from Arpen/AM (Associação dos Registradores Civis das Pessoas Naturais do Amazonas). The compiled excess death data are from Bruce Nelson from the Instituto Nacional de Pesquisas da Amazônia. (B) _R_t was calculated using the time series of COVID-19 hospitalisations after removal of the past 14 days to account for delays in notification. _R_t was calculated using the EpiFilter method. Lines are median _R_t estimates; shaded areas are the 95% CIs. _R_t=Effective reproduction number. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2.

Similar articles

Cited by

References

    1. Lucy CO, Verity R, Watson OJ, et al. Have deaths from COVID-19 in Europe plateaued due to herd immunity? Lancet. 2020;395:e110–e111. - PMC - PubMed
    1. Buss LF, Prete CA, Abrahim CMM, et al. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science. 2020;371:288–292. - PMC - PubMed
    1. Álvarez-Antonio C, Meza-Sánchez G, Calampa C, et al. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru. MedRxiv. 2021 doi: 10.1101/2021.01.17.21249913. published online 20. (preprint) - DOI - PMC - PubMed
    1. Fontanet A, Cauchemez S. COVID-19 herd immunity: where are we? Nat Rev Immunol. 2020;20:583–584. - PMC - PubMed
    1. Fundação de Vigilância em Saúde do Amazonas COVID-19 no Amazonas. Dados epidemiológicos e financeiros das ações de combate à COVID-19. Publicações. http://www.fvs.am.gov.br/publicacoes

Publication types

MeSH terms

Grants and funding

LinkOut - more resources